PL3481370T3 - Kompozycja farmaceutyczna zawierająca benzydaminę - Google Patents

Kompozycja farmaceutyczna zawierająca benzydaminę

Info

Publication number
PL3481370T3
PL3481370T3 PL17733862T PL17733862T PL3481370T3 PL 3481370 T3 PL3481370 T3 PL 3481370T3 PL 17733862 T PL17733862 T PL 17733862T PL 17733862 T PL17733862 T PL 17733862T PL 3481370 T3 PL3481370 T3 PL 3481370T3
Authority
PL
Poland
Prior art keywords
benzydamine
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
PL17733862T
Other languages
English (en)
Inventor
Antonello FAZIO
Serena Tongiani
Luca Donati
Claudio Milanese
Original Assignee
Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. filed Critical Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A.
Publication of PL3481370T3 publication Critical patent/PL3481370T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • A61K31/4161,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12Carboxylic acids; Salts or anhydrides thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183Amino acids, e.g. glycine, EDTA or aspartame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/06Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gynecology & Obstetrics (AREA)
  • Reproductive Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Dispersion Chemistry (AREA)
  • Oncology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
PL17733862T 2016-07-08 2017-07-03 Kompozycja farmaceutyczna zawierająca benzydaminę PL3481370T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP16178742 2016-07-08
EP17733862.1A EP3481370B1 (en) 2016-07-08 2017-07-03 Pharmaceutical composition comprising benzydamine
PCT/EP2017/066438 WO2018007288A1 (en) 2016-07-08 2017-07-03 Pharmaceutical composition comprising benzydamine

Publications (1)

Publication Number Publication Date
PL3481370T3 true PL3481370T3 (pl) 2021-10-11

Family

ID=56408999

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17733862T PL3481370T3 (pl) 2016-07-08 2017-07-03 Kompozycja farmaceutyczna zawierająca benzydaminę

Country Status (26)

Country Link
US (1) US20190224168A1 (pl)
EP (1) EP3481370B1 (pl)
JP (1) JP7060526B2 (pl)
KR (1) KR20190026686A (pl)
CN (1) CN109562058A (pl)
AR (1) AR109254A1 (pl)
AU (1) AU2017294402A1 (pl)
BR (1) BR112018077430A2 (pl)
CA (1) CA3025863A1 (pl)
CY (1) CY1124250T1 (pl)
DK (1) DK3481370T3 (pl)
EA (1) EA037435B1 (pl)
ES (1) ES2877133T3 (pl)
HR (1) HRP20210762T1 (pl)
HU (1) HUE054775T2 (pl)
IL (1) IL264083A (pl)
LT (1) LT3481370T (pl)
MD (1) MD3481370T2 (pl)
MX (1) MX380435B (pl)
PL (1) PL3481370T3 (pl)
PT (1) PT3481370T (pl)
RS (1) RS62022B1 (pl)
SG (1) SG11201900033UA (pl)
SI (1) SI3481370T1 (pl)
SM (1) SMT202100351T1 (pl)
WO (1) WO2018007288A1 (pl)

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0389924B1 (en) 1989-03-31 1994-08-17 GRUPPO LEPETIT S.p.A. Use of purpuromycin in the treatment of vaginal infections
CA2009402A1 (en) * 1990-02-06 1991-08-06 Attilio J. De Sanctis Use of benzydamine and salts thereof for relief of pain associated with herpes viral infections and laser vaporization of condylomata
GB9610359D0 (en) 1996-05-17 1996-07-24 Edko Trading Representation Pharmaceutical compositions
US6913759B2 (en) * 2003-03-11 2005-07-05 Curatek Pharmaceuticals Holding, Inc. Gel composition and method for treatment of vaginal infections
ITMI20031640A1 (it) * 2003-08-08 2005-02-09 Mipharm S P A Base per gel bioadesivi.
EP1698336A1 (en) * 2005-03-01 2006-09-06 Ferrer Internacional, S.A. Antifungal compositions comprising Sertaconazole and either Hydrocortisone or an antibacterial agent
ITBO20050388A1 (it) * 2005-06-06 2006-12-07 Alfa Wassermann Spa Formulazione mucoadesive utili in dispositivi medici in preparazioni farmaceutiche
US20070264309A1 (en) 2006-01-20 2007-11-15 Chollet Janet A Method Of Treating Atrophic Vaginitis
KR20090029237A (ko) 2006-06-02 2009-03-20 피어 트리 파머슈티칼스 인코포레이티드 위축성 질염을 치료하는 방법
ITMI20071136A1 (it) 2007-06-04 2008-12-05 Velleja Res Srl Formulazioni topiche per la prevenzione e il trattamento degli stati infiammatori e/o infettivi dell'aera genitale
CN101219139A (zh) * 2007-12-24 2008-07-16 广西壮族自治区花红药业股份有限公司 盐酸苄达明栓剂及其制备方法
CN101214218A (zh) 2007-12-26 2008-07-09 广西壮族自治区花红药业股份有限公司 盐酸苄达明凝胶剂及其制备方法
MX2012000498A (es) * 2009-07-08 2012-04-30 Acraf Uso de bencidamina en el tratamiento de enfermedades dependientes de p40.
WO2013178749A1 (fr) * 2012-06-01 2013-12-05 Galderma Research & Development Nanocapsules lipidiques comprenant un rétinoide, nanodispersion et composition les contenant, leur procédé de préparation et leur utilisation en dermatologie
US10806697B2 (en) * 2012-12-21 2020-10-20 Therapeuticsmd, Inc. Vaginal inserted estradiol pharmaceutical compositions and methods
RS60508B1 (sr) * 2015-01-13 2020-08-31 Acraf Farmaceutska kompozicija za lečenje mikoza

Also Published As

Publication number Publication date
DK3481370T3 (da) 2021-06-07
CY1124250T1 (el) 2022-07-22
SMT202100351T1 (it) 2021-07-12
HRP20210762T1 (hr) 2021-06-25
IL264083A (en) 2019-01-31
ES2877133T3 (es) 2021-11-16
EP3481370B1 (en) 2021-03-24
PT3481370T (pt) 2021-05-28
WO2018007288A1 (en) 2018-01-11
JP2019520370A (ja) 2019-07-18
MX380435B (es) 2025-03-12
HUE054775T2 (hu) 2021-09-28
MX2018015637A (es) 2019-06-17
EP3481370A1 (en) 2019-05-15
EA037435B1 (ru) 2021-03-26
BR112018077430A2 (pt) 2019-04-02
EA201990160A1 (ru) 2019-06-28
JP7060526B2 (ja) 2022-04-26
RS62022B1 (sr) 2021-07-30
US20190224168A1 (en) 2019-07-25
MD3481370T2 (ro) 2021-08-31
SG11201900033UA (en) 2019-02-27
AR109254A1 (es) 2018-11-14
AU2017294402A1 (en) 2018-12-20
SI3481370T1 (sl) 2021-08-31
CN109562058A (zh) 2019-04-02
CA3025863A1 (en) 2018-01-11
LT3481370T (lt) 2021-08-25
KR20190026686A (ko) 2019-03-13

Similar Documents

Publication Publication Date Title
IL265260B (en) pharmaceutical preparations
IL265360A (en) Pharmaceutical composition
IL262654A (en) Pharmacy preparation
IL269061A (en) A pharmaceutical preparation containing Selexifag
IL265349A (en) Pharmaceutical composition
PT3426294T (pt) Formulação farmacêutica compreendendo anticorpo, ciclodextrina e metionina
IL266537A (en) pharmaceutical preparation
IL253570A0 (en) Pharmacy composition
IL253177A0 (en) Pharmacy preparation
IL263040A (en) Pharmaceutical composition comprising eteplirsen
ZA201807851B (en) Pharmaceutical formulation
PL3454838T3 (pl) Kompozycja farmaceutyczna
GB201615917D0 (en) Pharmaceutical composition
GB201615914D0 (en) Pharmaceutical composition
IL265436B (en) Pharmacy preparation
IL263999A (en) Pharmaceutical compositions
GB201615910D0 (en) Pharmaceutical composition
GB201511246D0 (en) Pharmaceutical formulation
PL3424500T3 (pl) Kompozycja farmaceutyczna zawierająca famitynib
ZA201705782B (en) Pharmaceutical compositions
GB201620519D0 (en) Pharmaceutical composition
IL264083A (en) A pharmaceutical preparation containing benzydamine
IL265428A (en) Pharmaceutical composition
HK40004836A (en) Pharmaceutical composition comprising benzydamine
PT3476391T (pt) Composição farmacêutica que compreende arginina para utilização no tratamento da doença de poliq